Stay updated on Amivantamab Combo vs. Osimertinib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Amivantamab Combo vs. Osimertinib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Amivantamab Combo vs. Osimertinib in NSCLC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page instead of the study record content, indicating access denial to the resource. The layout mirrors the site chrome with header and footer, but no study data is rendered.
    Difference
    0.5%
    Check dated 2026-09-26T17:24:11.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error page with a minimal header and a Home button. This indicates access to the study record is blocked.
    Difference
    16%
    Check dated 2026-09-19T19:14:05.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    Added a regional IDOR location label for Rio de Janeiro and noted NIH funding. Removed the longer 'Instituto D Or de Pesquisa e Ensino IDOR' name, and updated the page revision to v3.6.6.
    Difference
    0.1%
    Check dated 2026-08-29T18:44:29.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Added Moscow, Russia (postal code 121205) as a study location and inserted new dates 2026-07-30, 2026-08-20, and 2028-02-16; Removed Krasnogorsk, Russia (postal code 143423) and earlier dates 2026-07-02, 2026-07-06, and 2027-11-30.
    Difference
    0.2%
    Check dated 2026-08-22T16:10:14.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The page shows Revision: v3.6.5, indicating a new revision of the study record. This appears to be an internal maintenance update rather than a change to the study details or how the page functions.
    Difference
    15%
    Check dated 2026-08-08T09:53:33.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Footer revision label updated to Revision: v3.6.4, signaling a minor version update to the site's template without altering content.
    Difference
    0.0%
    Check dated 2026-07-25T01:02:32.000Z thumbnail image

Stay in the know with updates to Amivantamab Combo vs. Osimertinib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Amivantamab Combo vs. Osimertinib in NSCLC Clinical Trial page.